GERON CORP Financing Cash Flow
GERON CORP (GERN) reported Financing Cash Flow of $3.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- GERON CORP net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $1.38M, a 26.86% increase year-over-year.
- GERON CORP net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $2.42M, a 847.27% increase year-over-year.
- GERON CORP net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $378.00K, a 99.77% decline year-over-year.
- GERON CORP net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $542.00K, a 84.85% decline year-over-year.
- GERON CORP net cash provided by (used in) financing activities for fiscal 2025 was $2.27M, a 99.32% decline from fiscal 2024.
- GERON CORP net cash provided by (used in) financing activities for fiscal 2024 was $334.37M, a 7.64% decline from fiscal 2023.
- GERON CORP net cash provided by (used in) financing activities for fiscal 2023 was $362.02M, a 314.86% increase from fiscal 2022.
- GERON CORP net cash provided by (used in) financing activities for fiscal 2022 was $87.26M, a 79.72% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.81M 10-Q · filed 2026-08-05 | $4.19M derived: sum of 3 quarters · filed 2026-08-05 | $4.73M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $2.42M 10-Q · filed 2026-05-06 | $2.80M derived: sum of 2 quarters · filed 2026-05-06 | $3.35M derived: sum of 3 quarters · filed 2026-05-06 | $4.44M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $378.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $920.00K derived: sum of 2 quarters · filed 2026-03-02 | $2.01M derived: sum of 3 quarters · filed 2026-08-05 | $2.27M 10-K · filed 2026-03-02 |
| 2025-09-30 | $542.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $1.63M derived: sum of 2 quarters · filed 2026-08-05 | $1.89M 10-Q · filed 2025-11-07 | $168.05M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.35M 10-Q · filed 2026-08-05 | $167.51M derived: sum of 3 quarters · filed 2026-08-05 | $171.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $256.00K 10-Q · filed 2026-05-06 | $166.42M derived: sum of 2 quarters · filed 2026-05-06 | $170.00M derived: sum of 3 quarters · filed 2026-05-06 | $186.83M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $166.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $169.74M derived: sum of 2 quarters · filed 2026-03-02 | $186.57M derived: sum of 3 quarters · filed 2026-03-02 | $334.37M 10-K · filed 2026-03-02 |
| 2024-09-30 | $3.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $20.41M derived: sum of 2 quarters · filed 2025-11-07 | $168.21M 10-Q · filed 2025-11-07 | $201.49M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | $16.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $164.63M 10-Q · filed 2025-08-06 | $197.91M derived: sum of 3 quarters · filed 2026-03-02 | $227.26M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | $147.80M 10-Q · filed 2025-05-07 | $181.08M derived: sum of 2 quarters · filed 2026-03-02 | $210.43M derived: sum of 3 quarters · filed 2026-03-02 | $228.77M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $33.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $62.63M derived: sum of 2 quarters · filed 2026-03-02 | $80.97M derived: sum of 3 quarters · filed 2026-03-02 | $362.02M 10-K · filed 2026-03-02 |
| 2023-09-30 | $29.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $47.69M derived: sum of 2 quarters · filed 2024-11-07 | $328.74M 10-Q · filed 2024-11-07 | $340.66M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $18.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $299.39M 10-Q · filed 2024-08-08 | $311.31M derived: sum of 3 quarters · filed 2025-02-27 | $316.09M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $281.05M 10-Q · filed 2024-05-02 | $292.97M derived: sum of 2 quarters · filed 2025-02-27 | $297.75M derived: sum of 3 quarters · filed 2025-02-27 | |
| 2022-12-31 | $11.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $16.70M derived: sum of 2 quarters · filed 2025-02-27 | $87.26M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $4.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $75.34M 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $70.56M 10-Q · filed 2023-08-03 | |||
| 2021-12-31 | $19.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $19.64M derived: sum of 2 quarters · filed 2024-02-28 | $32.29M derived: sum of 3 quarters · filed 2024-02-28 | $48.56M 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $12.65M derived: sum of 2 quarters · filed 2022-11-07 | $28.92M 10-Q · filed 2022-11-07 | $28.34M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $12.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $28.92M 10-Q · filed 2022-08-11 | $28.34M derived: sum of 3 quarters · filed 2023-03-16 | $52.31M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $16.26M 10-Q · filed 2022-05-09 | $15.68M derived: sum of 2 quarters · filed 2023-03-16 | $39.66M derived: sum of 3 quarters · filed 2023-03-16 | $183.92M derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | -$581.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $23.39M derived: sum of 2 quarters · filed 2023-03-16 | $167.66M derived: sum of 3 quarters · filed 2023-03-16 | $168.35M 10-K · filed 2023-03-16 |
| 2020-09-30 | $23.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $168.24M derived: sum of 2 quarters · filed 2021-11-09 | $168.93M 10-Q · filed 2021-11-09 | $179.20M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-06-30 | $144.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $144.95M 10-Q · filed 2021-08-16 | $155.22M derived: sum of 3 quarters · filed 2022-03-10 | $164.21M derived: sum of 4 quarters · filed 2022-03-10 |
| 2020-03-31 | $686.00K 10-Q · filed 2021-05-10 | $10.96M derived: sum of 2 quarters · filed 2022-03-10 | $19.94M derived: sum of 3 quarters · filed 2022-03-10 | |
| 2019-12-31 | $10.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $19.26M derived: sum of 2 quarters · filed 2022-03-10 | $19.50M 10-K · filed 2022-03-10 | |
| 2019-09-30 | $8.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $9.23M 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $243.00K 10-Q · filed 2020-08-06 | |||
| 2018-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $9.10M derived: sum of 2 quarters · filed 2021-03-11 | $91.42M derived: sum of 3 quarters · filed 2021-03-11 | $92.97M 10-K · filed 2021-03-11 |
| 2018-09-30 | $9.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $91.41M derived: sum of 2 quarters · filed 2019-11-06 | $92.96M 10-Q · filed 2019-11-06 | $94.03M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-06-30 | $82.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $83.87M 10-Q · filed 2019-08-01 | $84.95M derived: sum of 3 quarters · filed 2020-03-12 | $84.95M derived: sum of 4 quarters · filed 2020-03-12 |
| 2018-03-31 | $1.55M 10-Q · filed 2019-05-02 | $2.63M derived: sum of 2 quarters · filed 2020-03-12 | $2.63M derived: sum of 3 quarters · filed 2020-03-12 | |
| 2017-12-31 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.07M derived: sum of 2 quarters · filed 2020-03-12 | $1.11M 10-K · filed 2020-03-12 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $37.00K 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | $37.00K 10-Q · filed 2018-07-31 | |||
| 2016-12-31 | $1.17M 10-K · filed 2019-03-07 | |||
| 2016-06-30 | $1.07M 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $2.58M 10-K · filed 2018-03-16 | |||
| 2012-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $79.00K 10-Q · filed 2012-08-03 | -$4.11M derived: sum of 3 quarters · filed 2012-08-03 | $177.00K derived: sum of 4 quarters · filed 2012-08-03 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-07 | -$4.19M derived: sum of 2 quarters · filed 2012-05-07 | $98.00K derived: sum of 3 quarters · filed 2012-05-07 | $242.00K derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-12-31 | -$4.19M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-07 | $98.00K derived: sum of 2 quarters · filed 2012-03-07 | $242.00K derived: sum of 3 quarters · filed 2012-08-03 | $386.00K 10-K · filed 2012-03-07 |
| 2011-09-30 | $4.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $4.43M derived: sum of 2 quarters · filed 2012-08-03 | $4.58M 10-Q · filed 2011-11-03 | $98.46M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-06-30 | $144.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $288.00K 10-Q · filed 2012-08-03 | $94.18M derived: sum of 3 quarters · filed 2012-08-03 | $94.21M derived: sum of 4 quarters · filed 2012-08-03 |
| 2011-03-31 | $144.00K 10-Q · filed 2012-05-07 | $94.03M derived: sum of 2 quarters · filed 2012-05-07 | $94.07M derived: sum of 3 quarters · filed 2012-05-07 | |
| 2010-12-31 | $93.89M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-07 | $93.92M derived: sum of 2 quarters · filed 2012-03-07 | $104.11M 10-K · filed 2012-03-07 | |
| 2010-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $10.23M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $10.19M 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | $51.63M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |